Torrey Growth & Income Advisors Makes New Investment in SPDR S&P Biotech ETF $XBI

Torrey Growth & Income Advisors bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 4,856 shares of the exchange traded fund’s stock, valued at approximately $765,000.

A number of other institutional investors have also added to or reduced their stakes in XBI. Vestor Capital LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 548.6% in the 3rd quarter. Vestor Capital LLC now owns 2,737 shares of the exchange traded fund’s stock worth $432,000 after purchasing an additional 2,315 shares in the last quarter. Almanack Investment Partners LLC. raised its holdings in shares of SPDR S&P Biotech ETF by 45.6% during the 3rd quarter. Almanack Investment Partners LLC. now owns 6,129 shares of the exchange traded fund’s stock valued at $966,000 after buying an additional 1,920 shares in the last quarter. Elite Wealth Management Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $14,076,000. Endowment Wealth Management Inc. lifted its position in SPDR S&P Biotech ETF by 20.3% in the 3rd quarter. Endowment Wealth Management Inc. now owns 7,709 shares of the exchange traded fund’s stock worth $1,216,000 after buying an additional 1,300 shares during the last quarter. Finally, StoneX Group Inc. lifted its position in SPDR S&P Biotech ETF by 52.3% in the 3rd quarter. StoneX Group Inc. now owns 7,642 shares of the exchange traded fund’s stock worth $1,205,000 after buying an additional 2,624 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $156.90 on Tuesday. The firm has a market cap of $10.59 billion, a P/E ratio of 11.47 and a beta of 0.87. The stock has a 50 day simple moving average of $155.11 and a two-hundred day simple moving average of $142.43. SPDR S&P Biotech ETF has a 1 year low of $109.28 and a 1 year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.